Hong Kong Exchanges and Clearing Limited

FORM 3B - Director/Chief Executive Notice – Interests in Shares of Associated Corporation

Form Serial Number:

DB20210924E00069

1. Date of relevant event:

21/09/2021
(dd/mm/yyyy)

2. Date when director became aware of the relevant event / interest in the shares (if later):

(dd/mm/yyyy)

3. Stock code:

00876

4. Name of listed corporation:

Kaisa Health Group Holdings Ltd.

5. Name of associated corporation of listed corporation:

Kaisa Capital Investment Holdings Limited

6. Registered office:

Windward 3, Regatta Office Park, P.O. Box 1350, Grand Cayman KY1-1108, Cayman Islands

7. Principal place of business:

Unit 3610, 36/F., The Center, 99 Queen’s Road Central, Central, Hong Kong

8. Class of shares in which interested:

Ordinary shares

9. Number of issued shares in class:

1,060,000,000

12. Exchange on which listed:

The Stock Exchange of Hong Kong Limited

13. Name of director (English) as printed on HKID Card/Passport:

(Surname)	Kwok
(Other names)	Hiu Yan

16. Name of director (Chinese):

郭晓欣

17. Chinese Character Code as printed on HKID Card:

30. Details of relevant event:

Brief description of relevant event

Capacity in which shares were/are held

Number of shares bought/sold or involved

Currency of transaction

On Exchange

Off Exchange

Before relevant event

After relevant event

Highest price (per share)

Average price (per share)

Average consideration (per share)

Nature of consideration

Long position

1113	The number of shares in which you are interested has increased because: any other event (you must briefly describe the relevant event in the Supplementary Information box)

2201	Interest of corporation controlled by you

600,020,000

Short position

31. Total shares immediately before the relevant event:

	Total number of shares	Percentage figure (%)
Long position	0	0.00
Short position	0	0.00

32. Total shares immediately after the relevant event:

	Total number of shares	Percentage figure (%)
Long position	600,020,000	56.60

33. Capacity in which interests disclosed in Box 32 are held:

Capacity code

Number of shares

2201	Interest of corporation controlled by you

Long position

275,600,000

2501	Other (you must describe the capacity in the Supplementary Information box)

Long position

324,420,000

34. Further information in derivative interests in associated corporation:

Derivatives code

Exercise period (dd/mm/yyyy)

Consideration - if derivatives granted by associated corporation

Number of shares

		Begins	Ends	Currency	Price for grant	Currency	Exercise price	Currency	Price on assignment

35. Further information in relation to interests of children under 18 and/or spouse:

Child/Spouse	Name of child/spouse	Number of shares

36. Further information in relation to interests of corporations controlled by director:

Name of controlled corporation

Address and place of incorporation

Name of controlling person

% control

Direct interest (Y/N)

Number of shares

Excel Range Investments Limited

3rd Floor, J & C Building, Road Town, Tortola, British Virgin Islands, VG 1110

Kwok Hiu Yan

33.33

Long position

275,600,000

37. Further information in relation to interests held by director jointly with another person:

Name of joint shareholder	Address	Number of shares

38. Further information from a trustee, a beneficiary of a trust, or a person who has set up a discretionary trust:

Names of Trust	Address	Status code	Number of shares

39. Supplementary information:

Ms. Kwok has been appointed as an executive director of Kaisa Health Group Holdings Ltd. since 21 September 2021. To supplement on Box 33, the capacity code of 2501 refers to the interests held by Mighty Empire Group Limited, a party acting in concert wiht Excel Range Investments Limited which is controlled by Ms. Kwok.

40. Log/Serial Number of the previous form:

Date of filing this Form 3B:

24/09/2021
(dd/mm/yyyy)